Free Trial

Quipt Home Medical (QIPT) Stock Price, News & Analysis

-0.08 (-2.49%)
(As of 05/23/2024 ET)
Today's Range
50-Day Range
52-Week Range
293,054 shs
Average Volume
292,256 shs
Market Capitalization
$133.24 million
P/E Ratio
Dividend Yield
Price Target

Quipt Home Medical MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.80 Rating Score
131.6% Upside
$7.25 Price Target
Short Interest
1.61% of Float Sold Short
Dividend Strength
News Sentiment
-0.41mentions of Quipt Home Medical in the last 14 days
Based on 22 Articles This Week
Insider Trading
Proj. Earnings Growth

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.04 out of 5 stars

Medical Sector

558th out of 915 stocks

Surgical & Medical Instruments Industry

63rd out of 95 stocks

QIPT stock logo

About Quipt Home Medical Stock (NASDAQ:QIPT)

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

QIPT Stock Price History

QIPT Stock News Headlines

Quipt Home Medical Corp (QIPT)
Stocks in play: Quipt Home Medical Corp
QIPT Apr 2024 10.000 call
Quipt Home Medical just downgraded at Raymond James, here's why
Canadian CPI Due Next Week
See More Headlines
Receive QIPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quipt Home Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
5 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$221.74 million
Cash Flow
$0.87 per share
Book Value
$2.59 per share


Free Float
Market Cap
$133.24 million
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Gregory J. Crawford
    Chairman, President & CEO
  • Mr. Hardik Mehta
    Chief Financial Officer
  • Mr. David Bachelder
    Executive Vice President of Operations
  • Mr. William Todd Zehnder (Age 49)
    Chief Strategy Officer & Investor Relations
    Comp: $308.24k
  • Cole Stevens
    VP of Corporate Development & VP of Investor Relations
  • Mr. Mark Miles
    Vice President of Information Technology
  • Mr. Thomas W. Roehrig (Age 58)
    Executive Vice President of Finance
  • Mr. Robert Grossman LLB (Age 50)
    Corporate Secretary

QIPT Stock Analysis - Frequently Asked Questions

Should I buy or sell Quipt Home Medical stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quipt Home Medical in the last twelve months. There are currently 1 sell rating, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" QIPT shares.
View QIPT analyst ratings
or view top-rated stocks.

What is Quipt Home Medical's stock price target for 2024?

5 brokers have issued 1-year price objectives for Quipt Home Medical's shares. Their QIPT share price targets range from $2.50 to $9.50. On average, they anticipate the company's share price to reach $7.25 in the next twelve months. This suggests a possible upside of 131.6% from the stock's current price.
View analysts price targets for QIPT
or view top-rated stocks among Wall Street analysts.

How have QIPT shares performed in 2024?

Quipt Home Medical's stock was trading at $5.09 at the beginning of 2024. Since then, QIPT stock has decreased by 38.5% and is now trading at $3.13.
View the best growth stocks for 2024 here

When is Quipt Home Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024.
View our QIPT earnings forecast

How were Quipt Home Medical's earnings last quarter?

Quipt Home Medical Corp. (NASDAQ:QIPT) announced its quarterly earnings results on Sunday, August, 22nd. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.16. The business had revenue of $26.24 million for the quarter, compared to analyst estimates of $26.80 million. Quipt Home Medical had a negative trailing twelve-month return on equity of 3.89% and a negative net margin of 1.71%.

Who are Quipt Home Medical's major shareholders?

Quipt Home Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Claret Asset Management Corp (10.55%), Kennedy Capital Management LLC (2.24%), First Eagle Investment Management LLC (1.56%), Russell Investments Group Ltd. (1.20%), Connors Investor Services Inc. (0.12%) and Bridge City Capital LLC (0.11%).

How do I buy shares of Quipt Home Medical?

Shares of QIPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:QIPT) was last updated on 5/24/2024 by Staff

From Our Partners